About Ocera | Management

Laurent Fischer   Scott Harris   Dana S. McGowan   Keith E. Anderson
Karen K. Church    Akiko Shibata    Caroline S. LaPlaca

Caroline S. LaPlaca, Executive Director, Clinical Research Operations

Ms. LaPlaca has more than 26 years of experience in regulated industry with over 15 years of experience specifically related to drug development in the biopharmaceutical industry. Ms. LaPlaca was formerly Senior Director of Clinical Research Operations for Vical, Inc. Prior to Vical, she held positions in Clinical Research Operations, Clinical Quality and Training, GCP Compliance, and Regulatory Affairs with companies such as Elan Pharmaceuticals, Baxter BioScience, CoCensys, Vestar, and Sigma-Tau Pharmaceuticals. While at Baxter BioScience she developed and led a Global Clinical Quality and Training function providing a number of services to Clinical Operations including vendor qualification audits, clinical site audits, and ICH/GCP training. In addition she has held positions with several CROs (Quintiles Pacific and Paragon Biomedical) in the areas of clinical trial management and regulatory support. Ms. LaPlaca holds a B.S. and M.S. with Distinction in Biology from Georgetown University.